Form D · Biotechnology
CardioGenics Holdings Inc.
Mississauga, A6 · CIK 0001089029
Offering snapshot reported Feb 9, 2011 · SEC filing
- Reported sold
- $1.92M Offering amount: $2M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $20K Reported outside-investor minimum
- First sale
- Oct 13, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 9, 2011 | Initial | $1,915,575 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-155120
Source: Form D, filed Feb 9, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Essex | Executive |
| Yahia Gawad | Director, Executive |
| Alexander Dg Reid | Director |
| Linda Sterling | Director, Executive |
| J. Neil Tabatznik | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6295 Northam Drive Unit 8
Mississauga, A6, L4V 1W8
Mississauga, A6, L4V 1W8